# Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases:

> **NCT02890121** · — · COMPLETED · sponsor: **Fundación Pública Andaluza Progreso y Salud** · enrollment: 2006 (actual)

## Conditions studied

- Systemic Autoimmune Diseases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02890121
- **Lead sponsor:** Fundación Pública Andaluza Progreso y Salud
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2017-10
- **Final completion:** 2017-10
- **Target enrollment:** 2006 (ACTUAL)
- **Last updated:** 2018-05-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02890121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02890121, "Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases:". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT02890121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*